GL1X · GenesisL1 explorer

Research workbench

Inactivation of subtilisin carlsberg by N-(tert-butoxycarbonyl-alanyl- prolyl-phenylalanyl)-O-benzol hydroxylamine: formation of covalent enzyme-inhibitor linkage in the form of a carbamate derivative

Analyse Inactivation of subtilisin carlsberg by N-(tert-butoxycarbonyl-alanyl… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1SCN
Type
protein
Length
274 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Subtilisin carlsberg
EC
3.4.21.62
UniProt
P00780
Ligands
0EF, CA, NA
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ESubtilisin carlsberg (EC 3.4.21.62)protein27429% helix, 20% strandP00780

Ligands and binding sites

  • 0EF · N-(tert-butoxycarbonyl)-L-alanyl-N-[(1R)-1-(carboxyamino)-2-phenylethyl]-L-prolinamide · ligand · chains E
  • CA · Calcium ion · metal · 2 copies · chains E
  • NA · Sodium ion · metal · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1890.370.7626empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 1SCN · Inactivation of subtilisin carlsberg by N-(tert-butoxycarbonyl-alanyl-prolyl-phenylalanyl)… · the same entry in another collection · chain E against E, TM-score 1.00
  • P00780 · AlphaFold monomer V2.0 prediction for subtilisin carlsberg (P00780) · a predicted model of the same protein · chain E against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.